or Try an Advanced Search...

    Treatment Of Central Nervous System Disorders Stocks List

    Symbol Grade Name % Change
    VNDA B Vanda Pharmaceuticals Inc. -1.75
    BNOX F Bionomics Limited 2.05
    TRVN F Trevena, Inc. 7.35
    NRXP F NeuroRx, Inc. 0.64
    View As Page of Charts
    Related Industries: Biotechnology Conglomerates
    Related Stock Lists: Central Nervous System Disorders Biopharmaceutical Nervous System Disorders Organic Compounds Pyridines Acute And Chronic Pain Acute Pain Alcohol Alzheimer's Disease Analgesics Antidepressants Antineoplastic Drugs Anxiolytics Atypical Antipsychotics Bipolar Depression Bipolar Disorder Camidanlumab Tesirine Cancer Cancer Treatment Cell Signaling

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Central Nervous System Disorders stocks.

    Symbol Grade Name Weight
    IBRN D iShares Neuroscience and Healthcare ETF 0.53
    AFSM C Active Factor Small Cap ETF 0.45
    LABD B Direxion Daily S&P Biotech Bear 3X Shares 0.35
    SBIO D ALPS Medical Breakthroughs ETF 0.18
    OMFS C Invesco Russell 2000 Dynamic Multifactor ETF 0.15
    View all Treatment Of Central Nervous System Disorders ETFs...
    Compare ETFs
    Compare AFSM to LABD Compare IBRN to OMFS Compare IBRN to SBIO

        Treatment Of Central Nervous System Disorders Stocks Recent News

        Date Stock Title
        Apr 25 VNDA UPDATE 1-Shareholder Capital asks Vanda Pharma's board to reconsider Future Pak's offer
        Apr 25 VNDA Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals
        Apr 24 VNDA Vanda Pharmaceuticals (VNDA) Stock Sinks As Market Gains: What You Should Know
        Apr 24 VNDA Vanda (VNDA) to Report Q1 Earnings: What's in the Cards?
        Apr 22 VNDA Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ® ANDA Litigation
        Apr 22 VNDA US Supreme Court Declines To Hear Vanda Pharmaceuticals' Case Regarding Invalidation Of Patents For Its Sleep Disorder Drug, Hetlioz
        Apr 22 VNDA UPDATE 1-U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents
        Apr 22 VNDA US Supreme Court reportedly declines to hear Vanda patent case
        Apr 22 VNDA U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents
        Apr 19 VNDA Vanda under pressure from hedge fund to discuss Future Pak takeover offer
        Apr 19 VNDA Butler Hall Capital urges Vanda to engage in sales discussions
        Related Industries: Biotechnology Conglomerates
        Related Stock Lists: Central Nervous System Disorders Biopharmaceutical Nervous System Disorders Organic Compounds Pyridines Acute And Chronic Pain Acute Pain Alcohol Alzheimer's Disease Analgesics Antidepressants Antineoplastic Drugs Anxiolytics Atypical Antipsychotics Bipolar Depression Bipolar Disorder Camidanlumab Tesirine Cancer Cancer Treatment Cell Signaling
        Treatment Of Central Nervous System Disorders

        Treatment of central nervous system disorders can involve a variety of approaches, including medications, physical therapy, occupational therapy, speech therapy, psychotherapy, and lifestyle changes. Depending on the specific disorder, treatment may focus on symptom management, slowing the progression of the disorder, or finding a cure.

        Browse All Tags